ScholarIQanswers from OpenAlex & ORCID
Frans Van de Werf
ResearcherPublications, citations & collaboration network
Frans Van de Werf is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Frans Van de Werf have?
ScholarIQindexed works
Frans Van de Werf has 1,346 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Frans Van de Werf have?
ScholarIQcitation count
Frans Van de Werf has 67,860 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Frans Van de Werf?
ScholarIQh-index
Frans Van de Werf has an h-index of 119 in OpenAlex.
What is the i10-index of Frans Van de Werf?
ScholarIQi10-index
Frans Van de Werf has an i10-index of 517 in OpenAlex.
What is the ORCID of Frans Van de Werf?
ScholarIQorcid
The ORCID for Frans Van de Werf is on the source record.
What is the OpenAlex record for Frans Van de Werf?
ScholarIQopenalex
The OpenAlex for Frans Van de Werf is on the source record.
What are the most-cited papers on Frans Van de Werf?
ScholarIQmost cited works
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
Marco Valgimigli, Héctor Bueno, Robert A. Byrne, Jean‐Philippe Collet, Francesco Costa, Anders Jeppsson, Peter Jüni, Adnan Kastrati, Philippe Kolh, Laura Mauri, Gilles Montalescot, Franz‐Josef Neumann, Mate Petričević, Marco Roffi, Philippe Gabríel Steg, Stephan Windecker, Jose Luis Zamorano, Glenn N. Levine, ESC Scientific Document Group, Lina Badimón, Pascal Vranckx, Stefan Agewall, Felicita Andreotti, Elliott M. Antman, Emanuele Barbato, Jean‐Pierre Bassand, Raffaele Bugiardini, Mustafa Çıkırıkçıoğlu, Thomas Cuisset, Michele De Bonis, Victora Delgado, Donna Fitzsimons, Oliver Gaemperli, Nazzareno Galiè, Martine Gilard, Christian W. Hamm, Borja Ibáñez, Bernard Iung, Stefan James, Juhani Knuuti, Ulf Landmesser, Christophe Leclercq, Maddalena Lettino, Gregory Y.H. Lip, Massimo Piepoli, Luc Piérard, Markus Schwerzmann, Udo Sechtem, Iain A Simpson, Miguel Sousa‐Uva, Eugenio Stabile, Robert F. Storey, Michał Tendera, Frans Van de Werf, Freek W.A. Verheugt, Victor Aboyans, Stephan Windecker, Victor Aboyans, Stefan Agewall, Emanuele Barbato, Héctor Bueno, António Coca, Jean‐Philippe Collet, Ioan Mircea Coman, Verónica Dean, Victoria Delgado, Donna Fitzsimons, Oliver Gaemperli, Gerhard Hindricks, Bernard Iung, Peter Jüni, Hugo A. Katus, Juhani Knuuti, Patrizio Lancellotti, Christophe Leclercq, Theresa A. McDonagh, Massimo Piepoli, Piotr Ponikowski, Dimitrios Richter, Marco Roffi, Е. V. Shlyakhto, Iain A Simpson, Jose Luis Zamorano, Stephan Windecker, Victor Aboyans, Stefan Agewall, Emanuele Barbato, Héctor Bueno, António Coca, Jean‐Philippe Collet, Ioan Mircea Coman, Verónica Dean, Victoria Delgado, Donna Fitzsimons, Oliver Gaemperli, Gerhard Hindricks, Bernard Iung, Peter Jüni, Hugo A. Katus, Juhani Knuuti
Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both
Marc A. Pfeffer, John J.V. McMurray, Eric J. Velazquez, Jean‐Lucien Rouleau, Lars Køber, Aldo P. Maggioni, Scott D. Solomon, Karl Swedberg, Frans Van de Werf, Harvey D. White, Jeffrey D. Leimberger, Marc Henis, Susan Edwards, Steven L. Zelenkofske, Mary Ann Sellers, Robert M. Califf
Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE)
Keith A.A. Fox, Omar Dabbous, Robert J. Goldberg, Karen S. Pieper, Kim A. Eagle, Frans Van de Werf, Álvaro Avezum, Shaun G. Goodman, Marcus Flather, Frederick A. Anderson, Christopher B. Granger
A Validated Prediction Model for All Forms of Acute Coronary Syndrome
Kim A. Eagle, Michael J. Lim, Omar Dabbous, Karen S. Pieper, Robert J. Goldberg, Frans Van de Werf, Shaun G. Goodman, Christopher B. Granger, Philippe Gabríel Steg, Joel M. Gore, Andrzej Budaj, Álvaro Avezum, Marcus Flather, Keith A.A. Fox, for the GRACE Investigators